Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa

Author:

Oke M. A.,Afolabi F. J.,Oyeleke O. O.,Kilani T. A.,Adeosun A. R.,Olanbiwoninu A. A.,Adebayo E. A.

Abstract

Ganoderma lucidum is a well-known medicinal mushroom that has been used for the prevention and treatment of different ailments to enhance longevity and health specifically in China, Japan, and Korea. It was known as “God’s herb” in ancient China as it was believed to prolong life, enhance the youthful spirit and sustain/preserve vitality. G. lucidum is seldom collected from nature and is substantially cultivated on wood logs and sawdust in plastic bags or bottles to meet the international market demand. Both in vitro and in vivo studies on the copious metabolic activities of G. lucidum have been carried out. Varied groups of chemical compounds including triterpenoids, polysaccharides, proteins, amino acids, nucleosides, alkaloids, steroids, lactones, lectins, fatty acids, and enzymes with potent pharmacological activities have been isolated from the mycelia and fruiting bodies of G. lucidum. Several researchers have reported the abundance and diversification of its biological actions triggered by these chemical compounds. Triterpenoids and polysaccharides of G. lucidum have been reported to possess cytotoxic, hepatoprotective, antihypertensive, hypocholesterolemic, antihistaminic effects, antioxidant, antimicrobial, anti-inflammatory, hypoglycemic antiallergic, neuroprotective, antitumor, immunomodulatory and antiangiogenic activities. Various formulations have been developed, patented, and utilized as nutraceuticals, cosmeceuticals, and pharmaceuticals from G. lucidum extracts and active compounds. Thus, this review presents current updates on emerging infectious diseases and highlights the scope, dynamics, and advances in infectious disease management with a particular focus on Ganoderma lucidum, an unutilized natural medicine as a promising future solution to emerging diseases in Africa. However, details such as the chemical compound and mode of action of each bioactive against different emerging diseases were not discussed in this study.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference342 articles.

1. Evaluation of selected culinary-medicinal mushrooms for antioxidant and ACE inhibitory activities;Abdullah;Evid. Based. Complement. Altern. Med.,2012

2. Mushroom nanobiotechnology: Concepts, developments and potentials;Adebayo;Microb. Nanobiotechnology

3. Antimicrobial and antioxidant activity of silver, gold and silver-gold alloy nanoparticles phytosynthesized using extract of opuntia ficus-indica;Adebayo;Opuntia Ficus-indica. Rev. Adv. Mater. Sci.

4. Antioxidant potential of the biosynthesized silver, gold and silver-gold alloy nanoparticles using Opuntia ficus indica extract;Adebayo;Fountain J. Nat. Appl. Sci.

5. Biosynthesis of silver, gold and silver–gold alloy nanoparticles using Persea americana fruit peel aqueous extract for their biomedical properties;Adebayo;Nanotechnol. Environ. Eng.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3